Simplex Trading’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$130K Buy
63,600
+61,600
+3,080% +$113K ﹤0.01% 5246
2026
Q1
$3.58K Sell
2,000
-11,900
-86% -$25.2K ﹤0.01% 8086
2025
Q4
$31.1K Buy
13,900
+4,000
+40% +$10.5K ﹤0.01% 6075
2025
Q3
$23K Buy
+9,900
New +$26.4K ﹤0.01% 7221
2024
Q4
Sell
-20,200
Closed -$38K 9391
2024
Q3
$38K Buy
20,200
+12,500
+162% +$28.4K ﹤0.01% 6143
2024
Q2
$18K Buy
+7,700
New +$20.7K ﹤0.01% 6993
2023
Q3
Sell
-300
Closed -$3K 9583
2023
Q2
$3K Hold
300
﹤0.01% 8262
2023
Q1
$3K Buy
+300
New +$3.19K ﹤0.01% 8342

Other funds holding PROK

Simplex Trading's PROK Position: Q2 2026 in Review

Simplex Trading sold out of ProKidney (PROK) in Q2 2026, closing a stake of 6,741 shares — an estimated $12.3K sold.

Simplex Trading first reported a position in PROK in Q3 2023 and held it in 4 quarters. The position peaked at $193K in Q4 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Simplex Trading reported no remaining ProKidney position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 6,741 ProKidney shares in Q2 2026, an estimated $12.3K.
  • Simplex Trading first reported a position in ProKidney in Q3 2023 and held it in 4 quarters.
  • Simplex Trading's ProKidney position peaked at $193K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.